New York State Common Retirement Fund Has $91,000 Stock Holdings in ZimVie Inc. (NASDAQ:ZIMV)

New York State Common Retirement Fund trimmed its holdings in ZimVie Inc. (NASDAQ:ZIMV) by 39.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,518 shares of the company’s stock after selling 4,300 shares during the quarter. New York State Common Retirement Fund’s holdings in ZimVie were worth $91,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Segall Bryant & Hamill LLC bought a new stake in shares of ZimVie during the third quarter worth $891,000. Barclays PLC raised its holdings in ZimVie by 338.4% during the 3rd quarter. Barclays PLC now owns 43,437 shares of the company’s stock worth $690,000 after purchasing an additional 33,529 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in ZimVie by 66.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company’s stock worth $2,911,000 after purchasing an additional 73,395 shares during the last quarter. Geode Capital Management LLC lifted its position in ZimVie by 2.4% during the 3rd quarter. Geode Capital Management LLC now owns 646,564 shares of the company’s stock valued at $10,263,000 after purchasing an additional 15,053 shares during the period. Finally, Principal Financial Group Inc. bought a new position in shares of ZimVie in the 3rd quarter valued at about $275,000. Institutional investors and hedge funds own 95.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC reaffirmed a “buy” rating and set a $23.00 target price on shares of ZimVie in a report on Thursday, February 27th.

ZimVie Price Performance

NASDAQ ZIMV opened at $13.35 on Thursday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. The stock has a market cap of $369.49 million, a price-to-earnings ratio of -1.02 and a beta of 2.10. The business has a 50 day simple moving average of $13.73 and a 200 day simple moving average of $14.66. ZimVie Inc. has a 52-week low of $12.25 and a 52-week high of $22.40.

ZimVie (NASDAQ:ZIMV) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.02. The firm had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. Analysts anticipate that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.